[HTML][HTML] High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive …

F Moges, S Eshetie, W Abebe, F Mekonnen… - PloS one, 2019 - journals.plos.org
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

[PDF][PDF] High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen, M Dagnew… - PLoS ONE, 2019 - academia.edu
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen, M Dagnew… - Plos one, 2019 - europepmc.org
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

[HTML][HTML] High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive …

F Moges, S Eshetie, W Abebe, F Mekonnen… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

M Feleke, E Setegn, A Wondwossen, M Feleke… - PLoS ONE, 2019 - cabdirect.org
Background: Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

FM Feleke Moges, SE Setegn Eshetie… - 2019 - cabidigitallibrary.org
Background: Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen… - PLoS …, 2019 - search.ebscohost.com
Background: Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen, M Dagnew… - PLoS ONE, 2019 - go.gale.com
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …

[PDF][PDF] High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized …

F Moges, S Eshetie, W Abebe, F Mekonnen… - PLoS …, 2019 - pdfs.semanticscholar.org
Background Infections caused by extended-spectrum beta-lactamases (ESBL) producing
Gram-negative bacteria has emerge as a global threat in clinical practices. The treat is more …